Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study. (NCT06570980) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2023-08-25 |
Track Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin automatically
Every clearance here is in the API, with alerts when new ones post.